phosphonoacetic acid has been researched along with Acute Kidney Injury in 4 studies
Phosphonoacetic Acid: A simple organophosphorus compound that inhibits DNA polymerase, especially in viruses and is used as an antiviral agent.
phosphonoacetic acid : A member of the class of phosphonic acids that is phosphonic acid in which the hydrogen attached to the phosphorous is replaced by a carboxymethyl group.
Acute Kidney Injury: Abrupt reduction in kidney function. Acute kidney injury encompasses the entire spectrum of the syndrome including acute kidney failure; ACUTE KIDNEY TUBULAR NECROSIS; and other less severe conditions.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Foscarnet is an investigational antiviral agent that has been used effectively in the treatment of cytomegalovirus (CMV) retinitis in AIDS patients." | 7.68 | Successful foscarnet therapy for cytomegalovirus retinitis in an AIDS patient undergoing hemodialysis: rationale for empiric dosing and plasma level monitoring. ( Gambertoglio, JG; Graziani, AL; Grunwald, JE; MacGregor, RR; Weiss, R, 1991) |
| "Foscarnet is an investigational antiviral agent that has been used effectively in the treatment of cytomegalovirus (CMV) retinitis in AIDS patients." | 3.68 | Successful foscarnet therapy for cytomegalovirus retinitis in an AIDS patient undergoing hemodialysis: rationale for empiric dosing and plasma level monitoring. ( Gambertoglio, JG; Graziani, AL; Grunwald, JE; MacGregor, RR; Weiss, R, 1991) |
| "Foscarnet is a pyrophosphate analogue that has been successfully used in severe cytomegalovirus (CMV) infections." | 1.28 | Foscarnet nephrotoxicity: mechanism, incidence and prevention. ( Baumelou, A; Beaufils, H; Danis, M; Deray, G; Dohin, E; Gentilini, M; Katlama, C; Levaltier, B; Martinez, F; Rozenheim, M, 1989) |
| "Foscarnet (FC) is a new antiviral agent which has been recently proposed for the treatment of severe cytomegalovirus (CMV) infections in immunocompromised patients." | 1.27 | Acute renal failure induced by foscarnet: 4 cases. ( Baumelou, A; Cacoub, P; Deray, G; Gentilini, M; Jacobs, C; Le Hoang, P; Rousselie, R; Rozenbaum, W; Soubrie, C, 1988) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 3 (75.00) | 18.7374 |
| 1990's | 1 (25.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| MacGregor, RR | 1 |
| Graziani, AL | 1 |
| Weiss, R | 1 |
| Grunwald, JE | 1 |
| Gambertoglio, JG | 1 |
| Deray, G | 3 |
| Martinez, F | 1 |
| Katlama, C | 1 |
| Levaltier, B | 1 |
| Beaufils, H | 1 |
| Danis, M | 1 |
| Rozenheim, M | 1 |
| Baumelou, A | 3 |
| Dohin, E | 1 |
| Gentilini, M | 2 |
| Cacoub, P | 2 |
| Le Hoang, P | 2 |
| Rozenbaum, W | 1 |
| Soubrie, C | 2 |
| Rousselie, R | 1 |
| Jacobs, C | 2 |
| Rousselie, F | 1 |
| Morer, I | 1 |
4 other studies available for phosphonoacetic acid and Acute Kidney Injury
| Article | Year |
|---|---|
Successful foscarnet therapy for cytomegalovirus retinitis in an AIDS patient undergoing hemodialysis: rationale for empiric dosing and plasma level monitoring.
Topics: Acquired Immunodeficiency Syndrome; Acute Kidney Injury; Adult; Antiviral Agents; Cytomegalovirus In | 1991 |
Foscarnet nephrotoxicity: mechanism, incidence and prevention.
Topics: Acute Kidney Injury; Adult; Aged; Cohort Studies; Creatinine; Cytomegalovirus Infections; Fluid Ther | 1989 |
Acute renal failure induced by foscarnet: 4 cases.
Topics: Acquired Immunodeficiency Syndrome; Acute Kidney Injury; Adult; Antiviral Agents; Chorioretinitis; C | 1988 |
Foscarnet-induced acute renal failure and effectiveness of haemodialysis.
Topics: Acute Kidney Injury; Female; Foscarnet; Humans; Middle Aged; Organophosphorus Compounds; Phosphonoac | 1987 |